[ET Net News Agency, 15 April 2024] IMMUNEONCO-B (01541) rose 14.7% to HK$16.5,
breaking above the 20-D SMA of HK$15.524.
It hits an intra-day high of HK$16.5, and an intra-day low of HK$14.34. The total shares
traded was 162,200, with a value of HK$2.44m. The active buy/sell ratio is 92:8, with net
buying turnover of HK$2.05m. CHINA INV INFO accounts for greatest net responsive selling
turnover of HK$656,566, with volume weighted average price of HK$15.146.
Basic Information
=================
-----------------------------------
Nominal 16.500 % Chg +14.74%
High 16.500 Low 14.340
Shares Tr 162,200 Turnover 2.44m
10-D SMA 15.058 %H.V 82.341
20-D SMA 15.524 VWAP 15.058
50-D SMA 18.458 RSI14 50.098
-----------------------------------
Status: Breaking above the 20-D SMA, active buy/sell ratio is 92:8, with net buying
turnover of HK$2.05m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
IMMUNEONCO-B (01541) 16.50 +14.74
GENSCRIPT BIO (01548) 12.08 -5.33
INNOVENT BIO (01801) 35.80 -4.15
EVEREST MED-B (01952) 24.40 -6.69
LAEKNA-B (02105) 7.75 +61.12
SIRNAOMICS-B (02257) 7.75 +19.23
WUXI BIO (02269) 13.64 -1.87
TIGERMED (03347) 32.30 +0.16
AKESO (09926) 48.10 -2.83
REMEGEN (09995) 28.95 -10.23
---------------------------------------------
(ed)